ClinicalTrials.govpublic full text
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
colorectal neoplasms, intestinal neoplasms, gastrointestinal neoplasms, digestive system neoplasms, apatinib, bevacizumab, folfiri, colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903892
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.